Fujifilm Corporation has announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA.
The new site will be operated by Fujifilm Irvine Scientific, a manufacturer of cell culture solutions for life science research, bioproduction, cell therapy manufacturing, and medical applications.
The site will support cGMP manufacturing of animal component-free, dry powder, and liquid media, adding additional production capacity for Fujifilm Irvine Scientific.
As an area popular with life science companies, RTP in North Carolina was selected as an ideal location, providing enhanced supply chain security. Fujifilm’s group also operates cell culture media manufacturing facilities in California, USA, the Netherlands, and the Saitama and Aichi prefectures in Japan.
Yutaka Yamaguchi, Chairman, and Chief Executive Officer, Fujifilm Irvine Scientific, said: “The cell culture media that will be manufactured at this new site in North Carolina will help ensure a steady supply of raw materials for biologics, cell and gene therapies, and other key medicines that are essential to human health.”
